Condition

Liver Transplant; Complications

ClinicalTrials.gov condition label

Clinical trials9

Recruiting2

Common interventions10

Lead sponsors shown8

Clinical trials

9 shown

Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes MellitusNCT06060392 · 2023-10-30

CytOSorb TreatMent Of Critically Ill PatientS RegistryNCT05146336 · 2022-06-22

Semaglutide vs SitagliptinNCT05195944 · 2022-10-26

ENROLLING_BY_INVITATION

Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver TransplantationNCT05042505 · 2022-01-01

HHV8 and Solid Organ TransplantationNCT05081141 · 2021-09-15

Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive MedicationNCT04798625 · 2021-02-15

ACTIVE_NOT_RECRUITING

Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes MellitusNCT04216303 · 2019-09-12

Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ TransplantationNCT03946852 · 2019-06-01

Project LIFT - Promoting Healthy Behavior Through a Wearable Fitness Device and Financial IncentivesNCT03221465 · 2017-03-01

Common interventions

Sitagliptin 100mgDRUG2 Abdominal Regional PerfusionDEVICE1 CytoSorbDEVICE1 Dapagliflozin 10Mg TabDRUG1 Diagnostic test for HHV8 exposureDIAGNOSTIC_TEST1 hemoglobin A1cDIAGNOSTIC_TEST1 Self-monitoring of physical activity with incentivesBEHAVIORAL1 Semaglutide PillDRUG1 Semaglutide TreatmentDRUG1 Usual care and self-monitoring of physical activityBEHAVIORAL1

Leading sponsors

Medanta, The Medicity, India2 CytoSorbents, Inc1 Diakonhjemmet Hospital1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 London Health Sciences Centre1 Methodist Health System1 University Health Network, Toronto1 University of Pennsylvania1

Trial status mix

COMPLETED2

RECRUITING2

UNKNOWN2

ACTIVE_NOT_RECRUITING1

ENROLLING_BY_INVITATION1

WITHDRAWN1

Phase mix

NA4

PHASE41

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.